Drawing for AZENITY

USPTO serial 78490701

AZENITY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BELLO, ZACK
Law office
TMO LAW OFFICE 111 - DOCKET CLERK

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with AZENITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Wm. Charles Saunders

Wm. Charles Saunders AstraZeneca Pharmaceuticals LP1800 Concord PikeOW2Wilmington, DE 19850

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynaecology; pharmaceutical preparations and substances for the treatment and prevention of diabetesACTIVE—
009Video and audio media, namely, downloadable software, CD's, DVD's, tapes and discs, all relating to the treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system; video and audio media, namely, downloadable software, CD's, DVD's, tapes and discs, all relating to pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynaecology; video and audio media, namely, downloadable software, CD's, DVD's, tapes and discs, all relating to pharmaceutical preparations and substances for the treatment and prevention of diabetesACTIVE—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, syringes, catheters, nebulizers for respiration therapy, inhalers for therapeutic use, scalpels, blades, staplers, gloves, caps; artificial limbs, eyes and teeth; orthopedic articles, namely, hip prostheses, orthopedic joint implants, orthopedic supports, orthopedic support bandages, plaster casts for orthopedic purposes, belts, braces, footwear; suture materials,namely, sutures, surgical sutures, suture needlesACTIVE—
016Printed educational material, namely newsletters, brochures, booklets, a series of non-fiction books and periodical publications, namely, magazines, booklets, newsletters and brochures, all in the field of prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system, and in the field of pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynaecology, and in the field of pharmaceutical preparations and substances for the treatment and prevention of diabetesACTIVE—
035Preparing and placing advertisements for others by television, television screen based text, the internet, radio, cinema, magazines, booklets, newsletters and brochures and trade displays at conferences, conventions and meetings in the field of prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system, and in the field of pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynaecology, and in the field of pharmaceutical preparations and substances for the treatment and prevention of diabetesACTIVE—
044Medical services in the field of prevention and treatment of diseases and disorders of the respiratory system, central nervous system, peripheral nervous system, cardiovascular system, gastro-intestinal system, and in the field of pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, infection, inflammation, urology, gynaecology, and in the field of pharmaceutical preparations and substances for the treatment and prevention of diabetesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 6, 2007MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 5, 2007ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 30, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 30, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 7, 2007CNSIINQUIRY AS TO SUSPENSION MAILED—
Feb 6, 2007CNSISUSPENSION INQUIRY WRITTEN—
Aug 2, 2006CNSLLETTER OF SUSPENSION MAILED—
Aug 2, 2006CNSLSUSPENSION LETTER WRITTEN—
Aug 1, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 10, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2006MAILPAPER RECEIVED—
Jan 11, 2006CNSIINQUIRY AS TO SUSPENSION MAILED—
Jan 11, 2006CNSISUSPENSION INQUIRY WRITTEN—
Jun 28, 2005CNSLLETTER OF SUSPENSION MAILED—
Jun 27, 2005CNSLSUSPENSION LETTER WRITTEN—
Jun 16, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 9, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2005MAILPAPER RECEIVED—
Apr 29, 2005CPRAPRIORITY ACTION MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 28, 2005CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Apr 22, 2005DOCKASSIGNED TO EXAMINER—
Oct 4, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance